ВЛИЯНИЕ РЕТИНОЕВОЙ КИСЛОТЫ (ATRA) НА МИОМАТОЗНЫЙ УЗЕЛ (11-14)

Список литературы: Миома матки: диагностика, лечение и реабилитация. Клинические рекомендации по ведению больных / под ред. Л. В. Адамян [и др.]. – М.: Научный центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова, 2015. – 100 с. Activation of Rac1 and p38 Mitogen-activated protein kinase pathway in response to all-trans-retinoic acid /Alasyed Y., Uddin S., Mahmud N., Lekmine F., Kalvakolanu D. V., Minucci S. [et al.] // Journal of Biological Chemistry. – 2001. – Vol. 276. – P. 4012– 4019. Activin A is a potent activator of renal interstitial fibroblasts / S. Yamashita, A. Maeshima, I. Kojima, Y. Nojima // J. Am. Soc. Nephrol. – 2004. – Vol. 15. – P. 91–101. All-trans retinoic acid prevents radiation- or bleomycin-induced pulmonary fibrosis / Tabata C., Kadokawa Y., Tabata R., Takashi M., Okoshi K., Sakai Y. [et al.] // American Journal of Respiratory and Critical Care Medicine. – 2006. – Vol. 174. – P. 1352– 1360. All-trans retinoic acid regulates proliferation, migration, differentiation, and extracellular matrix turnover of human arterial smooth muscle cells / Axel D. I., Frigge A., Dittman J., Runge H., Spyridopoulos I., Riessen R. [et al.] // Cardiovascular Research. – 2001. – Vol. 49. – P. 851–862. Boettger-Tong H., Shipley G., Hsu C. J., Stancel G. M. Cultured human uterine smooth muscle cells are retinoid responsive // Proceedings of the Society for Experimental Biology and Medicine. – 1997. – Vol. 215. – P. 59–65. Duhan N. Current and emerging treatments for uterine myoma – an update / Int J Womens Health. – 2011. – Vol. 3. – P. 231–241. Malik M., Webb J., Catherino W. H. Retinoic acid treatment of human leiomyoma cells transformed the cell phenotype to one strongly resembling myometrial cells / Clin Endocrinol (Oxf). – 2008. – Vol. 69, № 3. – P. 462–470. Retinoic acid receptors: from molecular mechanisms to cancer therapy / di Masi A., Leboffe L., De Marinis E., Pagano F., Cicconi L., RochetteEgly C. // Mol Aspects Med. – 2015. – Vol. 41. – P. 1– 115. Retinoic Acid Signaling Pathways in Development and Diseases / Bhaskar C. D., Thapa P., Karki R., Das S., Mahapatra S., Liu T. C. [ et al.] // Bioorg Med Chem. – 2014. – Vol. 22, № 2. – P. 673– 683. Siddikuzzaman G., Guruvayoorappan C., Berlin Grace V. M. All trans retinoic acid and cancer // Immunopharmacol Immunotoxicol. – 2011. – Vol. 33, № 2. – P. 241–249. The place of selective progesterone receptor modulators in myoma therapy / Donnez J., Donnez O., Courtoy G. E., Dolmans M. M. // Minerva Ginecol. – 2016. – Vol. 68. – P. 313–320. Transcriptional regulation of plasminogen activator inhibitor-1 by transforming growth factorbeta, activin A and microphthalmia-associated transcription factor / Murakami M., Ikeda T., Saito T., Ogawa K., Nishino Y., Nakaya K., Funaba M. // Cell. Signal. – 2006. – Vol.18. – P. 256–265. Walton K. L., Johnson K. E., Harrison C. A. Targeting TGF-β Mediated SMAD Signaling for the Prevention of Fibrosis // Front Pharmacol. – 2017. – № 8. – P. 461.